Odyssey Therapeutics, Inc. (ODTX) Institutional Ownership Changes & 13F Activity
Odyssey Therapeutics, Inc. (ODTX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Tpg Gp A, Llc, Lightspeed Management Company, L.L.C., Orbimed Advisors Llc, Deerfield Management Company, L.P., and Hhlr Advisors, Ltd..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +32,125 | — | 32,125 | $601.06K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +222,450 | — | 222,450 | $4.16M | Q2 2026 | Sep 02, 2026 |
| General Catalyst Group Management, Llc | Buy | +810,272 | — | 810,272 | $15.16M | Q2 2026 | Aug 17, 2026 |
| Tpg Gp A, Llc | Buy | +3,690,146 | — | 3,690,146 | $69.04M | Q2 2026 | Aug 14, 2026 |
| Lightspeed Management Company, L.L.C. | Buy | +3,608,443 | — | 3,608,443 | $67.51M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Buy | +3,001,198 | — | 3,001,198 | $56.15M | Q2 2026 | Aug 14, 2026 |
| Deerfield Management Company, L.P. | Buy | +1,046,139 | — | 1,046,139 | $19.57M | Q2 2026 | Aug 14, 2026 |
| Hhlr Advisors, Ltd. | Buy | +831,656 | — | 831,656 | $15.56M | Q2 2026 | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | Buy | +725,000 | — | 725,000 | $13.56M | Q2 2026 | Aug 14, 2026 |
| Foresite Capital Management V, Llc | Buy | +713,105 | — | 713,105 | $13.34M | Q2 2026 | Aug 14, 2026 |
| Vivo Capital, Llc | Buy | +575,000 | — | 575,000 | $10.76M | Q2 2026 | Aug 14, 2026 |
| Ecor1 Capital, Llc | Buy | +555,555 | — | 555,555 | $10.39M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +521,736 | — | 521,736 | $9.76M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +471,987 | — | 471,987 | $8.83M | Q2 2026 | Aug 14, 2026 |
| Catalio Capital Management, Lp | Buy | +457,839 | — | 457,839 | $8.57M | Q2 2026 | Aug 14, 2026 |
| Redmile Group, Llc | Buy | +425,000 | — | 425,000 | $7.95M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Buy | +393,862 | — | 393,862 | $7.37M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +345,746 | — | 345,746 | $6.47M | Q2 2026 | Aug 14, 2026 |
| Boxer Capital Management, Llc | Buy | +275,000 | — | 275,000 | $5.15M | Q2 2026 | Aug 14, 2026 |
| Cormorant Asset Management, Lp | Buy | +175,000 | — | 175,000 | $3.27M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +156,602 | — | 156,602 | $2.93M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +132,801 | — | 132,801 | $2.48M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +101,531 | — | 101,531 | $1.90M | Q2 2026 | Aug 14, 2026 |
| Hudson Bay Capital Management Lp | Buy | +72,918 | — | 72,918 | $1.36M | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Buy | +64,621 | — | 64,621 | $1.21M | Q2 2026 | Aug 14, 2026 |
| Seven Grand Managers, Llc | Buy | +50,000 | — | 50,000 | $935.50K | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Buy | +49,658 | — | 49,658 | $929.10K | Q2 2026 | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Buy | +44,171 | — | 44,171 | $826.44K | Q2 2026 | Aug 14, 2026 |
| Ghisallo Capital Management Llc | Buy | +25,000 | — | 25,000 | $467.75K | Q2 2026 | Aug 14, 2026 |
| Burkehill Global Management, Lp | Buy | +20,000 | — | 20,000 | $374.20K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about ODTX activity
Which institutional owners are buying ODTX?
Institutional owners buying ODTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ODTX activity?
"Buy" means an investor increased their reported position in ODTX compared to the prior reporting period. This reflects growing exposure to Odyssey Therapeutics, Inc. (ODTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ODTX increasing?
Institutional interest in ODTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.